Show
Sort by
-
Prediction of recurrent event in patients with coronary heart disease : the EUROASPIRE Risk Model : results from a prospective study in 27 countries in the WHO European region-The EURObservational Research Programme (EORP) of the European Society of Cardiology (ESC)
-
2021 ESC guidelines on cardiovascular disease prevention in clinical practice
-
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)
-
- Journal Article
- A1
- open access
Repositioning of the global epicentre of non-optimal cholesterol
-
How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study
-
Investigations on the clinical utility of apolipoprotein B measurement : a research priority
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
-
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease : results from the EUROASPIRE IV survey
-
- Journal Article
- A1
- open access
Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia : on the need for a screening strategy in clinical practice : a report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology
-
Lipid-lowering nutraceuticals in clinical practice : position paper from an International Lipid Expert Panel